Probiotic Boosts Sleep | CBD Therapy Shows Early Promise

Novo Nordisk’s CagriSema bested by Lilly’s Zepbound in head-to-head trial.

Capricor to Present at 2026 MDA Conference | Neurent NEUROMARK Trial Positive

Japan Reviews GSK’s Hep B Drug | Neurizon Starts NUZ-001 HEALEY ALS Study

Roche Columvi Combo Delivers Sustained 3-Year Survival Benefit – Clinical News Update

Eli Lilly’s Orforglipron Tops Oral Semaglutide | FDA Reviews Vanda’s Imsidolimab

FibroBiologics Submits IND | Ascletis Clears FDA for Phase II Oral GLP-1 Trial

Tzield sBLA Gets Priority Review | Endeavor Health in Landmark Live CTE Study

CPP Phase 3 Trial Positive | Edgewise Advances EDG-7500 in Hypertrophic Cardiomyopathy

Ascletis Gets FDA OK for ASC30 Study | AZ’s Saphnelo Shows Strong Phase III SLE Data

$2M ALS Trial Support Announced | Ionis Wins Breakthrough Status for Zilganersen – Clinical News

FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous

Valneva Advances Zika Vaccine | Calico Earns FDA Orphan Drug – Clinical News Update Nod

GC Biopharma Secures IND OK in Korea for COVID-19 mRNA Vaccine Trial

Recross Cardio Enrolls First Patient | Granata Bio Reports Strong Phase III GRACE Enrollment

Kidney Drug Expansion Falls Short | Ionis Steps Up Angelman Awareness Campaign

Thermo Fisher Enrolls First Patient in PPD CorEvitas Alzheimer’s Registry

BioVersys’ AlpE TB Study Published in NEJM | Merck Shares Positive Enflonsia RSV Data

Zylox-Tonbridge Buys Optimed to Boost Global MedTech Reach

Functional Gut Clinic Launches Trials Unit | Pegrizeprument Gets Orphan Drug Status

Gefurulimab Succeeds in Phase 3 Trial | GC Biopharma’s Anthrax Vaccine Shines – Clinical News Update

MannKind Starts INHALE-1ST Paediatric Afrezza Study | Roche’s Fenebrutinib Hits Phase III PPMS Goal

Argenx Grounds Vyvgart Studies | Novo Oral Semaglutide Outshines Rivals – Clinical News Update

Novartis’ Remibrutinib Hits Trial Goal | SMSR–Sharda Launch MDR-TB Drug Monitoring Centre

Gilead HIV Pill Nears Filings | TempraMed Strengthens IP with Korea Patent

Novartis Vanrafia Shows Phase III Kidney Benefit in IgA Nephropathy | GLP-1s Linked to Fewer Asthma

EU Clears GSK’s Exdensur for Severe Asthma | Harness Nominates HRN001 for Huntington’s

Industry Leaders- Media coverage | Lifescience Intellipedia | Chemxpert Database | Clival Database

Myrtelle’s Canavan Trial Success | NeuroSense Marks Alzheimer’s Progress – Clinical News Update

Hoth Therapeutics Reports Positive MASLD Data | POLY-ACS Trial Highlights Polypill Strategy

Draig Begins Phase 2 for Depression | WHO Unveils New Bacterial Treatment Data– Clinical News Update

AstraZeneca Hits Phase 3 Milestone | Skye Bioscience Unveils CBeyond Results– Clinical News Update

ADC Therapeutics to Update on LOTIS-7 Trial – Clinical News Update

MetaVia Presents DA-1726 Data | Nanoscope’s Optogenetic Trial Shows Safety – Clinical News Update

Clival Database News Headlines | Daily News Headlines | 28 Jan 2025

Fresenius Kabi Recalls Famotidine Injection